Abstract

Annotation. Systemic lupus erythematosus (SLE) is a chronic disease characterized by a variety of clinical manifestations with phases of exacerbation and remission, which often complicate the clinician in determining treatment tactics or possible impact on its course of comorbid lesions, including those caused by viral infection. It is known that more than 90.0 % of patients with SLE are infected with cytomegalovirus (CMV) and about 99.5 % with Epstein–Barr virus (EBV). Because CMV and EBV can persist in the human body, more and more attention is being paid to elucidating the effects of active viral infection on the course and activity of SLE, the main pathogenetic mechanism of which is the autoimmune process. The aim of the study was to establish the frequency of cytomegalovirus and Epstein–Barr infections, and their combination in patients with systemic lupus erythematosus depending on the duration of the disease and the degree of its activity. The study involved 120 patients with SLE aged 18 to 69 years, who were in the rheumatology department of the Communal Non-Profit Enterprise of the Lviv Regional Council “Lviv Regional Clinical Hospital” in 2014–2019. To diagnose CMV and EBV infection, antibodies of immunoglobulins M and immunoglobulins G to viruses were detected in blood serum, as well as viruses were detected with polymerase chain reaction and groups of patients were formed: patients with active CMV infection; active EBV; active CMV and EBV; without active CMV and EBV. To achieve the goal, the study was conducted in two stages: determining the frequency of CMV and EBV infection and their combination depending on the duration of SLE (first) and the degree of its activity (second). Statistical analysis was performed in MS Excel using descriptive statistics, Student's t-test to compare samples with normal distribution, χ2-test, z-test to compare two particles; statistically significant relationship was considered when p<0.05. According to our results, active CMV infection is more common in patients with systemic lupus erythematosus duration less than 1 year, active EBV infection – in patients with disease duration greater than 10 years, a combination of active CMV and EBV infection – in patients with systemic lupus erythematosus duration less than 1 year. The increase in the degree of activity of systemic lupus erythematosus is accompanied by a significant (p<0.05) increase in the incidence of active CMV and EBV infection, as well as an increase in mean IgM and IgG antibody titers to these viruses in patients with increasing disease activity.

Highlights

  • ЧАСТОТА ЦИТОМЕГАЛОВІРУСНОЇ ТА ВІРУС ЕПШТЕЙНА-БАРР ІНФЕКЦІЇ, А ТАКОЖ ЇХ ПОЄДНАННЯ У ХВОРИХ НА СИСТЕМНИЙ ЧЕРВОНИЙ ВОВЧАК ЗАЛЕЖНО ВІД ТРИВАЛОСТІ НЕДУГИ ТА СТУПЕНЯ ЇЇ АКТИВНОСТІ

  • Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods

  • Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure

Read more

Summary

КЛІНІЧНІ ДОСЛІДЖЕННЯ

ЧАСТОТА ЦИТОМЕГАЛОВІРУСНОЇ ТА ВІРУС ЕПШТЕЙНА-БАРР ІНФЕКЦІЇ, А ТАКОЖ ЇХ ПОЄДНАННЯ У ХВОРИХ НА СИСТЕМНИЙ ЧЕРВОНИЙ ВОВЧАК ЗАЛЕЖНО ВІД ТРИВАЛОСТІ НЕДУГИ ТА СТУПЕНЯ ЇЇ АКТИВНОСТІ. Відповідно до отриманих нами результатів, активну цитомегаловірусну інфекцію частіше виявляють у хворих із тривалістю системного червоного вовчака менше 1 року, активну вірус Епштейна-Барр інфекцію - у хворих із тривалістю недуги більше 10 років, поєднання активної цитомегаловірусної та вірус Епштейна-Барр інфекції - у хворих, системний червоний вовчак яких триває менше 1 року. Мета дослідження - встановити частоту цитомегаловірусної та вірус Епштейна-Барр інфекції, а також їх поєднання у хворих на системний червоний вовчак залежно від тривалості недуги і ступеня її активності. Частота цитомегаловірусної та вірус Епштейна-Барр інфекції залежно від тривалості системного червоного вовчака (n; %; р)

Без активної ЦМВ та ЕБВ
Антитіла IgG до
Висновки та перспективи подальших розробок
Список посилань

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.